Plasma half-life of exogenously administered NAD+ is approximately 10 minutes in rodent pharmacokinetic studies, reflecting rapid uptake, ongoing metabolism, and continuous turnover by NAD+-consuming enzymes (PARPs, sirtuins, CD38)
Tissue Repair & Gut Research Overview BPC-157 , also known as Body Protection Compound-157 , is a synthetic pentadecapeptide widely discussed in preclinical research involving tissue repair models, tendon and ligament studies, gut barrier research, angiogenesis pathways, wound-healing biology and inflammatory response models
So far, it has been primarily tested on animals with limited human clinical trials
BPC-157 has been researched to: Improve healing of many types of wounds - Protect intestinal organs and prevents stomach ulcers - Combats leaky gut, IBS, gastrointestinal cramps and Crohns disease - Accelerate healing of skin burns - Work as an anti-inflammatory - Maintains integrity of mucosal lining GI tract - Repair tissues of GIT, tendons, ligaments, brain, bone, etc